KR100404303B1 - 올티프라즈의 간섬유화 및 간경화 진행의 예방 및치료제로서의 용도 및 올티프라즈를 주성분으로 함유하는제약 조성물 - Google Patents
올티프라즈의 간섬유화 및 간경화 진행의 예방 및치료제로서의 용도 및 올티프라즈를 주성분으로 함유하는제약 조성물 Download PDFInfo
- Publication number
- KR100404303B1 KR100404303B1 KR10-2001-0010686A KR20010010686A KR100404303B1 KR 100404303 B1 KR100404303 B1 KR 100404303B1 KR 20010010686 A KR20010010686 A KR 20010010686A KR 100404303 B1 KR100404303 B1 KR 100404303B1
- Authority
- KR
- South Korea
- Prior art keywords
- oltipraz
- liver
- fibrosis
- dmn
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
군 | ALT | AST | gamma-GT | 빌리루빈 |
대조군 | 49 ± 2 | 113 ± 6 | 0.2 ± 0.1 | 0.2 ± 0.01 |
DMN | 190 ± 12* | 412 ± 39* | 12.1 ± 4.1* | 0.9 ± 0.2* |
DMN + 올티프라즈50 mg/kg | 116 ± 4# | 246 ± 32# | 2.6 ± 0.5# | 0.3 ± 0.03# |
군 | 섬유화 수치 | Knodell 수치 |
대조군 | 0 | 0 |
DMN | 3.7±0.5 | 16.1±2.9 |
DMN + 올티프라즈 5 mg/kg | 3.1±0.4* | 11.1±1.7* |
DMN + 올티프라즈 15 mg/kg | 2.9±0.8* | 12.1±1.9* |
DMN + 올티프라즈 50 mg/kg | 2.5±0.9** | 8.0±1.6** |
대조군 | 올티프라즈30 μM | 올티프라즈100 μM | EGTA1 mM | 제니스타인100 μM | |
TGF-β 발현억제율 (%) | 0 | 30 | 60 | 80 | 80 |
Claims (3)
- 5-(2-피라지닐)-4-메틸-1,2-디티올-3-티온 및 제약상 허용되는 부형제를 함유하는, 간섬유화 및 간경화 진행의 예방 및 치료를 위한 제약 조성물.
- 제1항에 있어서, 제약 조성물이 캅셀제, 정제, 연질캅셀제, 현탁화제, 시럽제, 주사제 또는 산제로 이루어지는 군 중에서 선택된 제제로 제형화된 것인 제약 조성물.
- 제1항에 있어서, 상기 제약 조성물이 경구 투여를 위한 것인 제약 조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20000018134 | 2000-04-07 | ||
KR1020000018134 | 2000-04-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010091012A KR20010091012A (ko) | 2001-10-22 |
KR100404303B1 true KR100404303B1 (ko) | 2003-11-03 |
Family
ID=19662428
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2001-0010686A Expired - Fee Related KR100404303B1 (ko) | 2000-04-07 | 2001-03-02 | 올티프라즈의 간섬유화 및 간경화 진행의 예방 및치료제로서의 용도 및 올티프라즈를 주성분으로 함유하는제약 조성물 |
Country Status (16)
Country | Link |
---|---|
US (1) | US20030191137A1 (ko) |
EP (1) | EP1292309A4 (ko) |
JP (1) | JP2003530353A (ko) |
KR (1) | KR100404303B1 (ko) |
CN (1) | CN1192775C (ko) |
AU (1) | AU780161B2 (ko) |
BR (1) | BR0109747A (ko) |
CA (1) | CA2404915A1 (ko) |
HU (1) | HUP0300221A3 (ko) |
MX (1) | MXPA02009695A (ko) |
NO (1) | NO20024724L (ko) |
NZ (1) | NZ521710A (ko) |
PL (1) | PL362965A1 (ko) |
RU (1) | RU2258509C2 (ko) |
WO (1) | WO2001076604A1 (ko) |
ZA (1) | ZA200207867B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100590818B1 (ko) | 2004-10-11 | 2006-06-19 | 재단법인서울대학교산학협력재단 | 소분자 유기화합물의 직접적 p90 리보솜 S6 키나제 1(RSK1)의 활성증진에 의한 당뇨병, 비만 및대사증후군의 예방 및 치료용도 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7078045B2 (en) | 2000-03-02 | 2006-07-18 | Sang-Geon Kim | Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis |
KR20030067935A (ko) * | 2002-02-09 | 2003-08-19 | 김상건 | 올티프라즈를 포함하는 간경화(간경변증) 치료를 위한 간 조직 재생용 제약 조성물 |
KR100491318B1 (ko) * | 2002-11-26 | 2005-05-24 | 씨제이 주식회사 | 올티프라즈(Oltipraz) 제조방법 |
KR100476069B1 (ko) * | 2003-02-12 | 2005-03-10 | 주식회사 태평양 | 1,2-디티올티온 유도체를 함유하는 발모촉진용 또는탈모방지용 조성물 |
KR100629771B1 (ko) * | 2004-01-27 | 2006-09-28 | 씨제이 주식회사 | 결정성이 감소되거나 무정형화된 올티프라즈의 제조방법 |
KR100604261B1 (ko) | 2004-10-11 | 2006-07-28 | 재단법인서울대학교산학협력재단 | 신규4,5,6,7-테트라히드로-[1,2]디티올로[4,3-c]피리딘-3-티온계 화합물 |
KR20060031956A (ko) * | 2004-10-11 | 2006-04-14 | 재단법인서울대학교산학협력재단 | p90 리보솜 S6 키나제 1 (RSK1)의 직접적인 키나제활성증진을 통한 간섬유화와 간경변증 예방 및 치료용약학조성물 |
EP2026810A2 (en) * | 2006-05-11 | 2009-02-25 | Patrick T. Prendergast | Compositions and methods for modulating the immune system |
KR101057485B1 (ko) * | 2008-08-04 | 2011-08-17 | 서울대학교산학협력단 | 1,2-디티올티온 유도체를 함유하는 엘엑스알-알파 과다발현으로 인한 질병의 예방 및 치료용 약학 조성물 |
RU2016106641A (ru) * | 2013-07-30 | 2017-09-01 | Киото Прифекчурал Паблик Юниверсити Корпорэйшн | Терапевтические средства, направленные на ecm эндотелия роговицы |
PL3064222T3 (pl) | 2013-10-31 | 2021-04-19 | Kyoto Prefectural Public University Corporation | Lek terapeutyczny zawierający inhibitor sygnału tgf-beta w chorobach związanych z retikulum endoplazmatycznym i śmiercią komórki w śródbłonku rogówki |
US20160376259A1 (en) | 2015-06-25 | 2016-12-29 | St Ip Holding Ag | Methods for Preparing Oltipraz |
US11364239B2 (en) | 2020-04-29 | 2022-06-21 | Cfd Research Corporation | Compositions and methods for mitigating aflatoxin B1-induced liver injury |
CN112546216B (zh) * | 2020-11-20 | 2022-10-28 | 西湖大学 | 小分子化合物奥替普拉在制备增强体液免疫应答的药物中的应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE794873A (fr) * | 1972-02-02 | 1973-08-01 | Rhone Poulenc Sa | Nouvelles sulfones a enchainement dimethyl-1,6 hexadien-1,5 ylene |
DE2505869C3 (de) * | 1975-02-12 | 1978-05-18 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Herstellung von symmetrischen Carotinoiden |
JPS54160740A (en) * | 1978-06-09 | 1979-12-19 | Takeda Chem Ind Ltd | Anti-fibrotic agent |
US4883887A (en) * | 1987-07-09 | 1989-11-28 | Hoffmann-La Roche Inc. | Sulfone polyene intermediates |
US6517824B1 (en) * | 1990-05-14 | 2003-02-11 | University Of Medicine & Denistry Of New Jersey | Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor |
US5637315A (en) * | 1993-01-04 | 1997-06-10 | Thomas Jefferson University | Treatment of disease states induced by oxidative stress |
US5438141A (en) * | 1993-05-21 | 1995-08-01 | Merck Frosst Canada, Inc. | Heteroaryl and haloaryl quinoline derivatives of cyclopropaneacetic acid as leukotriene antagonists |
KR0138005B1 (ko) * | 1993-10-21 | 1998-05-15 | 김낙두 | 신규의 화학적 보호제(chemopreventive agent)및 그의 제조방법 |
CA2113229C (en) * | 1994-01-11 | 1999-04-20 | Mark Pines | Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof |
US5786344A (en) * | 1994-07-05 | 1998-07-28 | Arch Development Corporation | Camptothecin drug combinations and methods with reduced side effects |
EP0827742A1 (en) * | 1996-09-04 | 1998-03-11 | Vrije Universiteit Brussel | Use of histone deacetylase inhibitors for treating fribosis or cirrhosis |
JP2001507696A (ja) * | 1996-12-31 | 2001-06-12 | アンチオキシダント ファーマシューティカルズ コーポレーション | グルタチオンの医薬製剤およびその投与方法 |
US6294350B1 (en) * | 1997-06-05 | 2001-09-25 | Dalhousie University | Methods for treating fibroproliferative diseases |
US6046199A (en) * | 1998-01-14 | 2000-04-04 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives |
KR100261139B1 (ko) * | 1998-01-16 | 2000-08-01 | 황준수 | 신규한 알릴티오피리다진 유도체 및 그의 제조방법 |
US6242478B1 (en) * | 1999-12-10 | 2001-06-05 | Wake Forest University | Five member ring sulfenate esters and thiosulfinate esters |
RU2219935C1 (ru) * | 2002-07-09 | 2003-12-27 | НИИ онкологии им. проф. Н.Н. Петрова | Средство для профилактики рака |
-
2001
- 2001-03-02 EP EP01910187A patent/EP1292309A4/en not_active Withdrawn
- 2001-03-02 RU RU2002129873/15A patent/RU2258509C2/ru not_active IP Right Cessation
- 2001-03-02 US US10/240,491 patent/US20030191137A1/en not_active Abandoned
- 2001-03-02 BR BR0109747-4A patent/BR0109747A/pt not_active Application Discontinuation
- 2001-03-02 CA CA002404915A patent/CA2404915A1/en not_active Abandoned
- 2001-03-02 PL PL01362965A patent/PL362965A1/xx not_active Application Discontinuation
- 2001-03-02 NZ NZ521710A patent/NZ521710A/en unknown
- 2001-03-02 AU AU37767/01A patent/AU780161B2/en not_active Ceased
- 2001-03-02 JP JP2001574121A patent/JP2003530353A/ja active Pending
- 2001-03-02 MX MXPA02009695A patent/MXPA02009695A/es active IP Right Grant
- 2001-03-02 HU HU0300221A patent/HUP0300221A3/hu unknown
- 2001-03-02 KR KR10-2001-0010686A patent/KR100404303B1/ko not_active Expired - Fee Related
- 2001-03-02 CN CNB018073697A patent/CN1192775C/zh not_active Expired - Fee Related
- 2001-03-02 WO PCT/KR2001/000319 patent/WO2001076604A1/en not_active Application Discontinuation
-
2002
- 2002-10-01 ZA ZA200207867A patent/ZA200207867B/en unknown
- 2002-10-02 NO NO20024724A patent/NO20024724L/no not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100590818B1 (ko) | 2004-10-11 | 2006-06-19 | 재단법인서울대학교산학협력재단 | 소분자 유기화합물의 직접적 p90 리보솜 S6 키나제 1(RSK1)의 활성증진에 의한 당뇨병, 비만 및대사증후군의 예방 및 치료용도 |
Also Published As
Publication number | Publication date |
---|---|
CA2404915A1 (en) | 2001-10-18 |
JP2003530353A (ja) | 2003-10-14 |
KR20010091012A (ko) | 2001-10-22 |
RU2258509C2 (ru) | 2005-08-20 |
CN1420772A (zh) | 2003-05-28 |
MXPA02009695A (es) | 2003-03-27 |
AU780161B2 (en) | 2005-03-03 |
PL362965A1 (en) | 2004-11-02 |
NO20024724L (no) | 2002-11-29 |
EP1292309A1 (en) | 2003-03-19 |
AU3776701A (en) | 2001-10-23 |
RU2002129873A (ru) | 2004-03-27 |
WO2001076604A1 (en) | 2001-10-18 |
HUP0300221A3 (en) | 2003-09-29 |
NO20024724D0 (no) | 2002-10-02 |
EP1292309A4 (en) | 2004-08-11 |
HUP0300221A2 (hu) | 2003-07-28 |
NZ521710A (en) | 2004-06-25 |
ZA200207867B (en) | 2003-08-01 |
US20030191137A1 (en) | 2003-10-09 |
BR0109747A (pt) | 2003-02-04 |
CN1192775C (zh) | 2005-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2454996C2 (ru) | Применение ксантогумола и изоксантогумола в качестве активного вещества для профилактики и/или борьбы с заболеваниями печени | |
KR100404303B1 (ko) | 올티프라즈의 간섬유화 및 간경화 진행의 예방 및치료제로서의 용도 및 올티프라즈를 주성분으로 함유하는제약 조성물 | |
US20080004322A1 (en) | Methods of food intake management | |
US7728015B2 (en) | Compositions for weight management | |
WO2008122190A1 (fr) | Composition comprenant de la l-carnitine ou ses dérivés et son utilisation | |
JP2024019691A (ja) | 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法 | |
JP2022525202A (ja) | 肺動脈性肺高血圧症および各種疾患に伴う肺動脈性肺高血圧症の治療法と1日あたりの投薬量 | |
CA2473202C (en) | Pharmaceutical composition for regeneration of cirrhotic liver | |
WO2018062134A1 (en) | Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease | |
EP1263435B1 (en) | Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis | |
KR100377789B1 (ko) | 간섬유화 및 간경화 치료 및 예방용 의약 조성물 | |
US7078045B2 (en) | Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis | |
KR100473078B1 (ko) | 예덕나무피엑스를유효성분으로하는간기능개선제 | |
JPWO2020080451A1 (ja) | 糖尿病腎症における腎線維化抑制剤 | |
HK1117386A (en) | Method of treating liver cancer | |
CN101137386A (zh) | 肝癌的治疗方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20010302 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20030228 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20030923 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20031022 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20031023 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20061002 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20071001 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20081001 Start annual number: 6 End annual number: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20090921 Start annual number: 7 End annual number: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20100927 Start annual number: 8 End annual number: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20110920 Start annual number: 9 End annual number: 9 |
|
FPAY | Annual fee payment |
Payment date: 20120910 Year of fee payment: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20120910 Start annual number: 10 End annual number: 10 |
|
FPAY | Annual fee payment |
Payment date: 20130912 Year of fee payment: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20130912 Start annual number: 11 End annual number: 11 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20150909 |